US Patent Issued to TROBIO THERAPEUTICS on Jan. 20 for "Sulfonamide compounds and the use thereof in the treatment of cancer" (Australian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,792, issued on Jan. 20, was assigned to TROBIO THERAPEUTICS PTY LTD (Beecroft, Australia).

"Sulfonamide compounds and the use thereof in the treatment of cancer" was invented by Edna Hardeman (Beecroft, Australia), Peter Gunning (Beecroft, Australia) and Eleanor Eiffe (Beecroft, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to a class of sulfonamide-based compounds, compositions containing the same and the therapeutic use of the compounds in the treatment of cancer."

The patent was filed on Oct. 13, 2020, under Application No. 17/767,547.

*For further information, including images, charts and tab...